Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Japan

Nomura NEXT FUNDS TOPIX-17 Pharmaceutical ETF

+ Add to Watchlist

1621:JP

20,560.0000 JPY 50.0000 0.24%

As of 01:57:32 ET on 03/27/2015.

Snapshot for Nomura NEXT FUNDS TOPIX-17 Pharmaceutical ETF (1621)

Open: 20,600.0000 High - Low: 20,820.0000 - 20,400.0000 Primary Exchange: Tokyo
Volume: 519 52-Week Range: 13,840.0000 - 22,000.0000 Beta vs TP17PHRM: 0.9507

ETF Chart for 1621

No chart data available.
  • 1621:JP 20,560.0000
  • 1D
  • 1M
  • 1Y
20,610.0000
Interactive 1621 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 1621

NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF is an exchange-traded fund incorporated in Japan. The objective of the Fund is to provide investment results that correspond to the performance of the TOPIX-17 Pharmaceutical Index.

Inception Date: 2008-03-25 Telephone: 81-3-3241-9511
Managers: -
Web Site: www.nomura-am.co.jp

Fundamentals for 1621

NAV (on 2015-03-27) 20,441.1000
Assets (M) (on 2015-03-27) 849.0000
Shares out (M) 0.04
Market Cap (M) 854.33
% Premium 0.58
Average 52-Week % Premium 0.0105
Fund Leveraged N

Dividends for 1621

Dividend Type Distribution
Dividend Frequency Annual
Last Dividend Net (on 2014-07-11) 1,067.0000
Dividend Yield (ttm) 5.19%

Performance for 1621

1-Month +8.32% 1-Year +47.74%
3-Month +23.63% 3-Year +29.84%
Year To Date +24.98% 5-Year +17.18%
Expense Ratio 0.32

Top Fund Holdings for 1621

Filing Date: 02/27/2015
Name Position Value % of Total
Takeda Pharmaceutical Co Ltd 28,800 176,342,400 22.439%
Astellas Pharma Inc 87,600 166,527,600 21.191%
Eisai Co Ltd 10,100 63,044,200 8.022%
Otsuka Holdings Co Ltd 15,300 54,842,850 6.979%
Daiichi Sankyo Co Ltd 25,900 48,484,800 6.170%
Shionogi & Co Ltd 12,000 42,180,000 5.367%
Ono Pharmaceutical Co Ltd 3,500 41,650,000 5.300%
Chugai Pharmaceutical Co Ltd 7,700 28,066,500 3.571%
Santen Pharmaceutical Co Ltd 14,000 22,428,000 2.854%
Mitsubishi Tanabe Pharma Corp 9,000 18,126,000 2.307%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil